ZNF791 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.658760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.958400E-01
Normal-vs-Stage2
1.466770E-01
Normal-vs-Stage3
2.643800E-01
Normal-vs-Stage4
7.344800E-01
Stage1-vs-Stage2
2.871600E-01
Stage1-vs-Stage3
1.626280E-02
Stage1-vs-Stage4
8.256600E-01
Stage2-vs-Stage3
1.51209999965651E-07
Stage2-vs-Stage4
2.831800E-01
Stage3-vs-Stage4
4.030000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.510440E-01
Normal-vs-AfricanAmerican
6.222200E-01
Normal-vs-Asian
1.161570E-01
Caucasian-vs-AfricanAmerican
4.293400E-01
Caucasian-vs-Asian
2.380600E-01
AfricanAmerican-vs-Asian
2.239800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.659410E-01
Normal-vs-Female
1.940810E-01
Male-vs-Female
6.503800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.581000E-01
Normal-vs-Age(41-60Yrs)
3.430800E-01
Normal-vs-Age(61-80Yrs)
1.403190E-01
Normal-vs-Age(81-100Yrs)
6.283600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.496200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.748600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.378000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.180000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.283900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.597800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.839600E-02
Normal-vs-Daily Drinker
4.241800E-02
Normal-vs-Weekly Drinker
1.360430E-01
Normal-vs-Occasional Drinker
2.814200E-01
Normal-vs-Social Drinker
6.121400E-01
Non Drinker-vs-Daily Drinker
4.941800E-01
Non Drinker-vs-Weekly Drinker
8.261200E-01
Non Drinker-vs-Occasional Drinker
1.662570E-01
Non Drinker-vs-Social Drinker
1.153150E-01
Daily Drinker-vs-Weekly Drinker
4.677600E-01
Daily Drinker-vs-Occasional Drinker
7.637500E-02
Daily Drinker-vs-Social Drinker
3.695700E-02
Weekly Drinker-vs-Occasional Drinker
3.705400E-01
Weekly Drinker-vs-Social Drinker
1.992650E-01
Occasional Drinker-vs-Social Drinker
5.160400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.498100E-02
Normal-vs-Grade 2
1.937710E-02
Normal-vs-Grade 3
1.277740E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.751800E-01
Grade 1-vs-Grade 3
8.848800E-01
Grade 1-vs-Grade 4
8.498100E-02
Grade 2-vs-Grade 3
7.822600E-01
Grade 2-vs-Grade 4
1.937710E-02
Grade 3-vs-Grade 4
1.277740E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.379600E-02
Normal-vs-NonDiabetic
1.310630E-01
Diabetic-vs-NonDiabetic
5.800800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.694200E-01
Normal-vs-NoPancreatitis
1.312560E-01
Pancreatitis-vs-NoPancreatitis
5.350800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.547800E-01
Normal-vs-N1
1.481430E-01
N0-vs-N1
9.192800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.420200E-01
Normal-vs-TP53-NonMutant
5.384800E-01
TP53-Mutant-vs-TP53-NonMutant
1.839390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
